| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.091 | 13.619 | 19.218 | 49.097 | 50.621 | 32.480 | 46.080 | 24.929 | 188.403 | 81.426 |
| Total Income - EUR | 12.091 | 13.622 | 19.280 | 49.311 | 50.673 | 32.558 | 45.917 | 24.929 | 188.403 | 81.426 |
| Total Expenses - EUR | 11.441 | 14.479 | 18.488 | 36.909 | 18.641 | 20.120 | 44.564 | 24.517 | 92.495 | 76.544 |
| Gross Profit/Loss - EUR | 650 | -857 | 792 | 12.401 | 32.032 | 12.438 | 1.354 | 412 | 95.908 | 4.882 |
| Net Profit/Loss - EUR | 287 | -1.129 | 600 | 11.901 | 31.526 | 12.123 | 950 | 188 | 94.221 | 3.722 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Bioeuro Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 1.732 | 3.649 | 6.365 | 4.891 | 6.534 | 5.888 | 6.103 |
| Current Assets | 4.911 | 3.017 | 4.206 | 10.239 | 32.536 | 39.032 | 41.743 | 40.157 | 176.991 | 124.228 |
| Inventories | 0 | 0 | 0 | 209 | 3.502 | 5.755 | 6.330 | 11.659 | 9.446 | 24.021 |
| Receivables | 0 | 0 | 2.006 | 4.871 | 9.836 | 11.572 | 7.783 | 7.560 | 96.686 | 11.859 |
| Cash | 3.786 | 1.904 | 1.106 | 4.085 | 18.144 | 20.672 | 26.619 | 19.925 | 69.849 | 10.154 |
| Shareholders Funds | -11.565 | -12.576 | -11.764 | 353 | 31.872 | 43.391 | 43.378 | 43.700 | 134.648 | 122.124 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 16.476 | 15.593 | 15.970 | 11.618 | 4.313 | 2.007 | 3.256 | 2.991 | 48.230 | 8.208 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6202 - 6202" | |||||||||
| CAEN Financial Year |
6202
|
|||||||||
Comments - Bioeuro Srl